TinyGemsBreaks Archive - Page 15 of 152

TuesdayJan 20, 2026 11:40 am

TinyGemsBreaks – To Participate In DealFlow Discovery Conference

Kairos Pharma (NYSE American: KAPA) announced it will participate in the DealFlow Discovery Conference to be held Jan. 28–29, 2026, at the Borgata Hotel, Casino & Spa in Atlantic City, N.J. The company said Chief Scientific Officer Neil Bhowmick will deliver a company presentation and conduct one-on-one meetings with investors during the event as Kairos continues advancing its clinical-stage oncology programs. To view the full press release, visit https://ibn.fm/0CBmk About Kairos Pharma Ltd. Based in Los Angeles, California, Kairos Pharma Ltd. ( NYSE American: KAPA ) is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression…

FridayJan 16, 2026 9:10 am

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Subsidiary Achieves Quantum Error Correction Breakthrough

Rail Vision (NASDAQ: RVSN) announced that its majority-owned subsidiary, Quantum Transportation Ltd., has achieved a technical breakthrough with the successful prototype development and validation of a first-generation transformer-based neural decoder designed to advance scalable quantum error correction. The Company said the code-agnostic solution demonstrated superior decoding accuracy and efficiency versus leading classical methods in comprehensive simulations across multiple quantum error correction codes and noise environments, supported by a completed intellectual property strategy. Management noted the milestone strengthens the strategic value of its investment in Quantum Transportation while the companies explore longer-term opportunities to apply advanced data analysis and computing methodologies…

FridayJan 16, 2026 9:00 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Agreement to Acquire Quantum Circuits Inc., Establishing World’s Leading Quantum Computing Company

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, and Quantum Circuits, Inc. (“Quantum Circuits”), a leading developer of error-corrected superconducting gate-model quantum computing systems, recently announced that the companies have entered into a merger agreement under which D-Wave will acquire Quantum Circuits for a purchase price of $550 million, consisting of $300 million in D-Wave common stock and $250 million in cash. By combining the world’s leading annealing quantum computing company with the world’s leading developer of error-corrected gate-model technology, D-Wave aims to dramatically…

ThursdayJan 15, 2026 9:45 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Reseller Agreement for Cyprus Homeland Security Market

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a reseller agreement with Lella Kentonis Investment Co. Limited, appointing the firm as its authorized reseller in Cyprus. Under the agreement, Lella Kentonis will distribute and integrate ParaZero’s counter-UAS product lines, including its DefendAir solutions, into the Cypriot defense and homeland security market, expanding ParaZero’s regional presence and supporting government and security agencies with net-based, mission-critical drone interception technologies. To view the full press release, visit https://ibn.fm/3bRLK About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry.…

ThursdayJan 15, 2026 9:00 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates First Scalable, On-Chip Cryogenic Control of Gate-Model Qubits

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, recently announced a breakthrough in gate-model quantum computing with the successful demonstration of scalable on-chip cryogenic control of qubits. This industry-first milestone advances the development of commercially viable gate-model quantum computers by significantly reducing the wiring required to control large numbers of qubits without degrading qubit fidelity. This achievement validates that the on-chip cryogenic control technology D-Wave developed for its commercial annealing quantum processing units (QPUs) can also be applied to its gate-model architectures. In D-WaveTM…

WednesdayJan 14, 2026 9:20 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Engages IBN to Expand Investor and Corporate Communications Reach

ParaZero Technologies (NASDAQ: PRZO) an aerospace defense company focused on smart, autonomous solutions for manned and unmanned aerial systems, has engaged IBN to support its corporate communications and investor outreach strategy. ParaZero specializes in multi-layered Counter-Unmanned Aircraft System (“Counter-UAS”) technologies designed to neutralize hostile drones in complex and RF-denied environments, including urban and strategic infrastructure settings. Through the engagement, IBN will leverage its global investor-focused distribution network, encompassing more than 5,000 syndication outlets, newsletters, social media channels, blogs, and InvestorWire services, to increase visibility for ParaZero’s expanding defense portfolio, which reflects ongoing collaboration with Israeli defense authorities and international security…

TuesdayJan 13, 2026 9:50 am

TinyGemsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Moves From Grid Intelligence Narrative to Execution Test

GridAI Technologies (NASDAQ: GRDX) sits at a critical inflection point for the grid intelligence sector, where rising power demand, constrained infrastructure timelines, and the need for real-time coordination have pushed software-driven orchestration from concept to operational necessity. The company’s relevance no longer hinges on vision or positioning but on measurable execution, specifically the amount of electrical load it actively forecasts, coordinates, and optimizes in live environments. GridAI operates at the control layer of energy economics, where customer trust is earned through consistent performance rather than pilots or demonstrations, and where the transition from testing to dependence signals durable adoption. For…

TuesdayJan 13, 2026 9:40 am

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Engages IBN to Support Corporate Communications Strategy

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company focused on advancing differentiated cancer therapies, announced that it has engaged IBN, a multifaceted financial news and publishing company, to support its corporate communications strategy. Through the engagement, IBN will leverage its investor-focused distribution platform, including more than 5,000 syndication outlets, newsletters, social media channels, blogs and wire services via InvestorWire, to increase awareness of LIXTE’s first-in-class approach to enhancing the effectiveness of existing chemotherapy and immunotherapy treatments, including its lead clinical candidate, LB-100, across cancers with significant unmet medical need. To view the full press release, visit https://ibn.fm/wlINV About LIXTE…

ThursdayJan 08, 2026 9:00 am

TinyGemsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

Lixte Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing clinical trial evaluating its proprietary compound LB-100 in combination with GSK’s Dostarlimab for the treatment of ovarian clear cell cancer. The trial, initiated in January 2024 and led by Amir Jazaeri, MD, at MD Anderson, has added a second site at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University under the direction of Emily M. Hinchcliff, MD, MPH, and is expected to double enrollment to 42 patients following completion of its…

WednesdayDec 17, 2025 12:25 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for primary and metastatic cancers of the brain and central nervous system, reported a leadership transition under which John Climaco has stepped down as chief executive officer and Rami Levin, MBA, has been appointed president and chief executive officer, effective Jan. 1, 2026. Levin brings nearly three decades of global leadership experience across oncology, neurology and rare diseases, with a track record of advancing late-stage clinical programs, scaling organizations and leading strategic turnarounds, positioning CNS to advance its pipeline and next phase of development. To view the full press release, visit https://ibn.fm/FBByV About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks